Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

CELESTONE SOLUSPAN

BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE

Standard Dose
3MG/ML;EQ 3MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CELESTONE SOLUSPAN is listed in Drugs@FDA under application 014602 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE Form and strength INJECTABLE;INJECTION - 3MG/ML;EQ 3MG BASE/ML Sponsor ORGANON Submission history Latest submission status date: 2024-07-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview CELESTONE SOLUSPAN is listed in Drugs@FDA under application 014602 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE Form and strength INJECTABLE;INJECTION - 3MG/ML;EQ 3MG BASE/ML Sponsor ORGANON Submission history Latest submission status date: 2024-07-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.